Snup Stada Special Precautions

There are isolated reports on severe side effects (especially apnea) after use of therapeutic dosages. Overdosing must be avoided by all means.
SNUP STADA may only be used after a careful benefit/risk assessment in: Patients treated with monoamine oxidase inhibitors (MAOIs) or with other potentially blood pressure-increasing drugs; Increased intraocular pressure, especially narrow-angle glaucoma; Severe cardiovascular diseases (e.g. coronary heart disease, hypertension); Pheochromocytoma; Metabolic disorders (e.g. hyperthyroidism, diabetes mellitus); Porphyria; Prostatic hypertrophy.
Especially after prolonged use and overdosing the effect of decongestants may lessen. As a result of this abuse of decongestants the following may occur: Reactive hyperemia of the nasal mucosa (rhinitis medicamentosa); Atrophy of the nasal mucosa.
To at least sustain nasal breathing to some extent, the sympathomimetic drug should be used first in one nostril and then switched to the other nostril once the complaints have cleared up.
Other precautions: SNUP STADA 0.1% spray is suitable for school children from 6 years of age and adults. It must not be used in children in the age group of less than 6 years of age.
Effects on ability to drive and use machines: When used as directed SNUP STADA has no influence on the ability to drive and use machines.